Chemical Conjugation-based Cell Surface Glycoengineering Service
Covalent Conjugation Strategy with Surface-Expressing Groups on Cells
The cell surface represents a complex chemical environment composed of proteins, carbohydrates, lipids, and other molecules. A variety of functional groups, such as amine groups and thiol groups, are naturally present on the cell surface, which facilitates direct covalent conjugations with appropriate chemical tools. In addition, artificially introducing groups onto the cell surface allows selective and specific modifications at the desired site. Chemical conjugation enables the introduction of unnatural functionalities, such as fluorophores, into cell surface glycans.
Fig.1 Covalent conjugation strategies with surface-expressing groups on cells. (Wang, et al., 2023)
Chemical Conjugation-based Cell Surface Glycoengineering Service at CD BioGlyco
At CD BioGlyco, we provide chemical conjugation-based cell surface glycoengineering services that cover the currently available chemical engineering tools for cell surface glycoengineering, including bio-orthogonal aldehyde-amine reaction, diels-alder reaction, click chemistry, hydrazone ligation, cyanogen bromide (CNBr) activation, periodate oxidation, Staudinger ligation, maleimide, fluorophore, biotin, chemical crosslinker.
Equipped with world-leading technology platforms and professional scientific staff in glycoengineering, CD BioGlyco is fully competent and dedicated to serving as your one-stop-shop for bioorthogonal aldehyde-amine reaction-based cell surface chemical conjugation glycoengineering service.
Diels-Alder Reaction-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco has extensive experience in chemical conjugation-based cell surface glycoengineering. Welcome clients from worldwide to inquire about our diels-alder reaction-based cell surface chemical conjugation glycoengineering service.
Click Chemistry-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco provides high-quality service to facilitate our clients' click chemistry-based cell surface chemical conjugation glycoengineering research.
Hydrazone Ligation-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco owns a team of technical experts to deal with any problem you may meet in hydrazone ligation-based cell surface chemical conjugation glycoengineering service.
Cyanogen Bromide (CNBr) Activation-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco has years of experience in CNBr activation-based cell surface chemical conjugation glycoengineering service, thus you can trustingly hand over any problem to us.
Periodate Oxidation-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco is proud to offer our clients periodate oxidation-based cell surface chemical conjugation glycoengineering service with the best quality.
Staudinger Ligation-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco is a leader in technologies for cell surface glycoengineering, providing efficient, accurate, and reproducible Staudinger ligation-based cell surface chemical conjugation glycoengineering service.
Maleimide-Thiol Coupling-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco provides a fast, cost-effective, and accurate maleimide-thiol coupling-based cell surface chemical conjugation glycoengineering service.
Fluorophore-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco has developed an advanced fluorophore-based cell surface chemical conjugation glycoengineering service to provide analysis service in various samples for our clients.
Biotin-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco has extensive experience in cell surface chemical conjugation glycoengineering. Welcome clients from worldwide to inquire about our biotin-based cell surface chemical conjugation glycoengineering service.
Chemical Crosslinker-based Cell Surface Chemical Conjugation Glycoengineering Service
CD BioGlyco provides chemical crosslinker-based cell surface chemical conjugation glycoengineering service at competitive quality.
Applications
- A variety of conjugation chemistry methodologies for the activation of polysaccharides have been used to couple carbohydrate antigens to protein carriers.
- The conjugation of various functional groups and biomolecules on the cell surface contributes to better functionality and further development for live cell imaging, drug delivery, control of cell surface interactions, cell tracking, and sensing biological environments in vitro and in vivo.
- Cell membrane glycoengineering has been widely applied in the endowment of cells with new abilities, glycoengineered membrane self-assembly servers as vehicles to coat nanoparticles, in vivo cell tracking, metabolic glycan labeling, cell and drug delivery, and single-cell encapsulation.
Advantages
- Among a variety of cell modification strategies, chemical engineering represents a reliable and straightforward approach to improving their therapeutic potential.
- Compared with genetic engineering or biological engineering approaches, chemical engineering methods have a relatively lower demand for deliberate manufacturing control and are more cost-effective and easier for scale-up production.
- As highly efficient in vitro glycoengineered expression platforms, chemical conjugation-based cell surface glycoengineering technologies have high flexibility and cost-effectiveness.
With proven experience in glycoscience, CD BioGlyco has accumulated substantial experience and expertise in cell line glycoengineering. By assembling top-class scientific experts and integrating state-of-the-art technologies, CD BioGlyco has established efficient Cell Surface Glycoengineering Platforms based on our Cell Surface Glycoengineering Technology that provides several custom services such as Cell Surface Glycoengineering Services. Our expression platforms provide custom functions to our client's needs. If you are interested in our services, please feel free to contact us for more information.
Reference
- Wang, Y.; et al. Chemically engineering cells for precision medicine. Chemical Society Reviews. 2023.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform
- Bioorthogonal Aldehyde-amine Reaction-based Cell Surface Chemical Conjugation Glycoengineering Service
- Diels-Alder Reaction-based Cell Surface Chemical Conjugation Glycoengineering Service
- Click Chemistry-based Cell Surface Chemical Conjugation Glycoengineering Service
- Hydrazone Ligation-based Cell Surface Chemical Conjugation Glycoengineering Service
- Cyanogen Bromide (CNBr) Activation-based Cell Surface Chemical Conjugation Glycoengineering Service
- Periodate Oxidation-based Cell Surface Chemical Conjugation Glycoengineering Service
- Staudinger Ligation-based Cell Surface Chemical Conjugation Glycoengineering Service
- Maleimide-Thiol Coupling-based Cell Surface Chemical Conjugation Glycoengineering Service
- Fluorophore-based Cell Surface Chemical Conjugation Glycoengineering Service
- Biotin-based Cell Surface Chemical Conjugation Glycoengineering Service
- Chemical Crosslinker-based Cell Surface Chemical Conjugation Glycoengineering Service




